Global Hospital Acquired Disease Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Publisher Name :
Date: 27-Aug-2022
No. of pages: 85

The Hospital Acquired Disease Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hospital Acquired Disease Testing market size is estimated to be worth US$ 466.3 million in 2021 and is forecast to a readjusted size of USD 959.1 million by 2028 with a CAGR of 10.9% during review period. Disease Testing accounting for % of the Hospital Acquired Disease Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Instrument and Reagents segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Hospital Acquired Disease Testing include Life technologies, Diatherix laboratories, Qiagen GmbH, Meridian Biosciences, and Nordion, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Hospital Acquired Disease Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Instrument and Reagents

- Consumables

Market segment by Application, can be divided into

- Disease Testing

- Drug-Resistance Testing

Market segment by players, this report covers

- Life technologies

- Diatherix laboratories

- Qiagen GmbH

- Meridian Biosciences

- Nordion

- Roche

- Cantel Medical Corporation

- Cepheid

Market segment by regions, regional analysis covers

- North America (United States, Canada, and Mexico)

- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

- South America (Brazil, Argentina, Rest of South America)

- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Hospital Acquired Disease Testing product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Hospital Acquired Disease Testing, with revenue, gross margin and global market share of Hospital Acquired Disease Testing from 2019 to 2022.

Chapter 3, the Hospital Acquired Disease Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Hospital Acquired Disease Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Hospital Acquired Disease Testing research findings and conclusion, appendix and data source.

Global Hospital Acquired Disease Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Hospital Acquired Disease Testing
1.2 Classification of Hospital Acquired Disease Testing by Type
1.2.1 Overview: Global Hospital Acquired Disease Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Hospital Acquired Disease Testing Revenue Market Share by Type in 2021
1.2.3 Instrument and Reagents
1.2.4 Consumables
1.3 Global Hospital Acquired Disease Testing Market by Application
1.3.1 Overview: Global Hospital Acquired Disease Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Disease Testing
1.3.3 Drug-Resistance Testing
1.4 Global Hospital Acquired Disease Testing Market Size & Forecast
1.5 Global Hospital Acquired Disease Testing Market Size and Forecast by Region
1.5.1 Global Hospital Acquired Disease Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Hospital Acquired Disease Testing Market Size by Region, (2017-2022)
1.5.3 North America Hospital Acquired Disease Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Hospital Acquired Disease Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Hospital Acquired Disease Testing Market Size and Prospect (2017-2028)
1.5.6 South America Hospital Acquired Disease Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Hospital Acquired Disease Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hospital Acquired Disease Testing Market Drivers
1.6.2 Hospital Acquired Disease Testing Market Restraints
1.6.3 Hospital Acquired Disease Testing Trends Analysis
2 Company Profiles
2.1 Life technologies
2.1.1 Life technologies Details
2.1.2 Life technologies Major Business
2.1.3 Life technologies Hospital Acquired Disease Testing Product and Solutions
2.1.4 Life technologies Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Life technologies Recent Developments and Future Plans
2.2 Diatherix laboratories
2.2.1 Diatherix laboratories Details
2.2.2 Diatherix laboratories Major Business
2.2.3 Diatherix laboratories Hospital Acquired Disease Testing Product and Solutions
2.2.4 Diatherix laboratories Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Diatherix laboratories Recent Developments and Future Plans
2.3 Qiagen GmbH
2.3.1 Qiagen GmbH Details
2.3.2 Qiagen GmbH Major Business
2.3.3 Qiagen GmbH Hospital Acquired Disease Testing Product and Solutions
2.3.4 Qiagen GmbH Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Qiagen GmbH Recent Developments and Future Plans
2.4 Meridian Biosciences
2.4.1 Meridian Biosciences Details
2.4.2 Meridian Biosciences Major Business
2.4.3 Meridian Biosciences Hospital Acquired Disease Testing Product and Solutions
2.4.4 Meridian Biosciences Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Meridian Biosciences Recent Developments and Future Plans
2.5 Nordion
2.5.1 Nordion Details
2.5.2 Nordion Major Business
2.5.3 Nordion Hospital Acquired Disease Testing Product and Solutions
2.5.4 Nordion Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Nordion Recent Developments and Future Plans
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Hospital Acquired Disease Testing Product and Solutions
2.6.4 Roche Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Roche Recent Developments and Future Plans
2.7 Cantel Medical Corporation
2.7.1 Cantel Medical Corporation Details
2.7.2 Cantel Medical Corporation Major Business
2.7.3 Cantel Medical Corporation Hospital Acquired Disease Testing Product and Solutions
2.7.4 Cantel Medical Corporation Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Cantel Medical Corporation Recent Developments and Future Plans
2.8 Cepheid
2.8.1 Cepheid Details
2.8.2 Cepheid Major Business
2.8.3 Cepheid Hospital Acquired Disease Testing Product and Solutions
2.8.4 Cepheid Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Cepheid Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hospital Acquired Disease Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Hospital Acquired Disease Testing Players Market Share in 2021
3.2.2 Top 10 Hospital Acquired Disease Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Hospital Acquired Disease Testing Players Head Office, Products and Services Provided
3.4 Hospital Acquired Disease Testing Mergers & Acquisitions
3.5 Hospital Acquired Disease Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Hospital Acquired Disease Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Hospital Acquired Disease Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Hospital Acquired Disease Testing Revenue Market Share by Application (2017-2022)
5.2 Global Hospital Acquired Disease Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Hospital Acquired Disease Testing Revenue by Type (2017-2028)
6.2 North America Hospital Acquired Disease Testing Revenue by Application (2017-2028)
6.3 North America Hospital Acquired Disease Testing Market Size by Country
6.3.1 North America Hospital Acquired Disease Testing Revenue by Country (2017-2028)
6.3.2 United States Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Hospital Acquired Disease Testing Revenue by Type (2017-2028)
7.2 Europe Hospital Acquired Disease Testing Revenue by Application (2017-2028)
7.3 Europe Hospital Acquired Disease Testing Market Size by Country
7.3.1 Europe Hospital Acquired Disease Testing Revenue by Country (2017-2028)
7.3.2 Germany Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
7.3.3 France Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Hospital Acquired Disease Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Hospital Acquired Disease Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Hospital Acquired Disease Testing Market Size by Region
8.3.1 Asia-Pacific Hospital Acquired Disease Testing Revenue by Region (2017-2028)
8.3.2 China Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
8.3.5 India Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Hospital Acquired Disease Testing Revenue by Type (2017-2028)
9.2 South America Hospital Acquired Disease Testing Revenue by Application (2017-2028)
9.3 South America Hospital Acquired Disease Testing Market Size by Country
9.3.1 South America Hospital Acquired Disease Testing Revenue by Country (2017-2028)
9.3.2 Brazil Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Hospital Acquired Disease Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Hospital Acquired Disease Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Hospital Acquired Disease Testing Market Size by Country
10.3.1 Middle East & Africa Hospital Acquired Disease Testing Revenue by Country (2017-2028)
10.3.2 Turkey Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Hospital Acquired Disease Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Hospital Acquired Disease Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Hospital Acquired Disease Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Hospital Acquired Disease Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Hospital Acquired Disease Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Hospital Acquired Disease Testing Revenue Market Share by Region (2023-2028)
Table 6. Life technologies Corporate Information, Head Office, and Major Competitors
Table 7. Life technologies Major Business
Table 8. Life technologies Hospital Acquired Disease Testing Product and Solutions
Table 9. Life technologies Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Diatherix laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Diatherix laboratories Major Business
Table 12. Diatherix laboratories Hospital Acquired Disease Testing Product and Solutions
Table 13. Diatherix laboratories Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Qiagen GmbH Corporate Information, Head Office, and Major Competitors
Table 15. Qiagen GmbH Major Business
Table 16. Qiagen GmbH Hospital Acquired Disease Testing Product and Solutions
Table 17. Qiagen GmbH Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Meridian Biosciences Corporate Information, Head Office, and Major Competitors
Table 19. Meridian Biosciences Major Business
Table 20. Meridian Biosciences Hospital Acquired Disease Testing Product and Solutions
Table 21. Meridian Biosciences Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Nordion Corporate Information, Head Office, and Major Competitors
Table 23. Nordion Major Business
Table 24. Nordion Hospital Acquired Disease Testing Product and Solutions
Table 25. Nordion Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Roche Corporate Information, Head Office, and Major Competitors
Table 27. Roche Major Business
Table 28. Roche Hospital Acquired Disease Testing Product and Solutions
Table 29. Roche Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Cantel Medical Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Cantel Medical Corporation Major Business
Table 32. Cantel Medical Corporation Hospital Acquired Disease Testing Product and Solutions
Table 33. Cantel Medical Corporation Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Cepheid Corporate Information, Head Office, and Major Competitors
Table 35. Cepheid Major Business
Table 36. Cepheid Hospital Acquired Disease Testing Product and Solutions
Table 37. Cepheid Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Global Hospital Acquired Disease Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 39. Global Hospital Acquired Disease Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 40. Breakdown of Hospital Acquired Disease Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Hospital Acquired Disease Testing Players Head Office, Products and Services Provided
Table 42. Hospital Acquired Disease Testing Mergers & Acquisitions in the Past Five Years
Table 43. Hospital Acquired Disease Testing New Entrants and Expansion Plans
Table 44. Global Hospital Acquired Disease Testing Revenue (USD Million) by Type (2017-2022)
Table 45. Global Hospital Acquired Disease Testing Revenue Share by Type (2017-2022)
Table 46. Global Hospital Acquired Disease Testing Revenue Forecast by Type (2023-2028)
Table 47. Global Hospital Acquired Disease Testing Revenue by Application (2017-2022)
Table 48. Global Hospital Acquired Disease Testing Revenue Forecast by Application (2023-2028)
Table 49. North America Hospital Acquired Disease Testing Revenue by Type (2017-2022) & (USD Million)
Table 50. North America Hospital Acquired Disease Testing Revenue by Type (2023-2028) & (USD Million)
Table 51. North America Hospital Acquired Disease Testing Revenue by Application (2017-2022) & (USD Million)
Table 52. North America Hospital Acquired Disease Testing Revenue by Application (2023-2028) & (USD Million)
Table 53. North America Hospital Acquired Disease Testing Revenue by Country (2017-2022) & (USD Million)
Table 54. North America Hospital Acquired Disease Testing Revenue by Country (2023-2028) & (USD Million)
Table 55. Europe Hospital Acquired Disease Testing Revenue by Type (2017-2022) & (USD Million)
Table 56. Europe Hospital Acquired Disease Testing Revenue by Type (2023-2028) & (USD Million)
Table 57. Europe Hospital Acquired Disease Testing Revenue by Application (2017-2022) & (USD Million)
Table 58. Europe Hospital Acquired Disease Testing Revenue by Application (2023-2028) & (USD Million)
Table 59. Europe Hospital Acquired Disease Testing Revenue by Country (2017-2022) & (USD Million)
Table 60. Europe Hospital Acquired Disease Testing Revenue by Country (2023-2028) & (USD Million)
Table 61. Asia-Pacific Hospital Acquired Disease Testing Revenue by Type (2017-2022) & (USD Million)
Table 62. Asia-Pacific Hospital Acquired Disease Testing Revenue by Type (2023-2028) & (USD Million)
Table 63. Asia-Pacific Hospital Acquired Disease Testing Revenue by Application (2017-2022) & (USD Million)
Table 64. Asia-Pacific Hospital Acquired Disease Testing Revenue by Application (2023-2028) & (USD Million)
Table 65. Asia-Pacific Hospital Acquired Disease Testing Revenue by Region (2017-2022) & (USD Million)
Table 66. Asia-Pacific Hospital Acquired Disease Testing Revenue by Region (2023-2028) & (USD Million)
Table 67. South America Hospital Acquired Disease Testing Revenue by Type (2017-2022) & (USD Million)
Table 68. South America Hospital Acquired Disease Testing Revenue by Type (2023-2028) & (USD Million)
Table 69. South America Hospital Acquired Disease Testing Revenue by Application (2017-2022) & (USD Million)
Table 70. South America Hospital Acquired Disease Testing Revenue by Application (2023-2028) & (USD Million)
Table 71. South America Hospital Acquired Disease Testing Revenue by Country (2017-2022) & (USD Million)
Table 72. South America Hospital Acquired Disease Testing Revenue by Country (2023-2028) & (USD Million)
Table 73. Middle East & Africa Hospital Acquired Disease Testing Revenue by Type (2017-2022) & (USD Million)
Table 74. Middle East & Africa Hospital Acquired Disease Testing Revenue by Type (2023-2028) & (USD Million)
Table 75. Middle East & Africa Hospital Acquired Disease Testing Revenue by Application (2017-2022) & (USD Million)
Table 76. Middle East & Africa Hospital Acquired Disease Testing Revenue by Application (2023-2028) & (USD Million)
Table 77. Middle East & Africa Hospital Acquired Disease Testing Revenue by Country (2017-2022) & (USD Million)
Table 78. Middle East & Africa Hospital Acquired Disease Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Hospital Acquired Disease Testing Picture
Figure 2. Global Hospital Acquired Disease Testing Revenue Market Share by Type in 2021
Figure 3. Instrument and Reagents
Figure 4. Consumables
Figure 5. Hospital Acquired Disease Testing Revenue Market Share by Application in 2021
Figure 6. Disease Testing Picture
Figure 7. Drug-Resistance Testing Picture
Figure 8. Global Hospital Acquired Disease Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Hospital Acquired Disease Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Hospital Acquired Disease Testing Revenue Market Share by Region (2017-2028)
Figure 11. Global Hospital Acquired Disease Testing Revenue Market Share by Region in 2021
Figure 12. North America Hospital Acquired Disease Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Hospital Acquired Disease Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Hospital Acquired Disease Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Hospital Acquired Disease Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Hospital Acquired Disease Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Hospital Acquired Disease Testing Market Drivers
Figure 18. Hospital Acquired Disease Testing Market Restraints
Figure 19. Hospital Acquired Disease Testing Market Trends
Figure 20. Life technologies Recent Developments and Future Plans
Figure 21. Diatherix laboratories Recent Developments and Future Plans
Figure 22. Qiagen GmbH Recent Developments and Future Plans
Figure 23. Meridian Biosciences Recent Developments and Future Plans
Figure 24. Nordion Recent Developments and Future Plans
Figure 25. Roche Recent Developments and Future Plans
Figure 26. Cantel Medical Corporation Recent Developments and Future Plans
Figure 27. Cepheid Recent Developments and Future Plans
Figure 28. Global Hospital Acquired Disease Testing Revenue Share by Players in 2021
Figure 29. Hospital Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 30. Global Top 3 Players Hospital Acquired Disease Testing Revenue Market Share in 2021
Figure 31. Global Top 10 Players Hospital Acquired Disease Testing Revenue Market Share in 2021
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 33. Global Hospital Acquired Disease Testing Revenue Share by Type in 2021
Figure 34. Global Hospital Acquired Disease Testing Market Share Forecast by Type (2023-2028)
Figure 35. Global Hospital Acquired Disease Testing Revenue Share by Application in 2021
Figure 36. Global Hospital Acquired Disease Testing Market Share Forecast by Application (2023-2028)
Figure 37. North America Hospital Acquired Disease Testing Sales Market Share by Type (2017-2028)
Figure 38. North America Hospital Acquired Disease Testing Sales Market Share by Application (2017-2028)
Figure 39. North America Hospital Acquired Disease Testing Revenue Market Share by Country (2017-2028)
Figure 40. United States Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Hospital Acquired Disease Testing Sales Market Share by Type (2017-2028)
Figure 44. Europe Hospital Acquired Disease Testing Sales Market Share by Application (2017-2028)
Figure 45. Europe Hospital Acquired Disease Testing Revenue Market Share by Country (2017-2028)
Figure 46. Germany Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Hospital Acquired Disease Testing Sales Market Share by Type (2017-2028)
Figure 52. Asia-Pacific Hospital Acquired Disease Testing Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Hospital Acquired Disease Testing Revenue Market Share by Region (2017-2028)
Figure 54. China Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Japan Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. South Korea Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. India Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Southeast Asia Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Australia Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South America Hospital Acquired Disease Testing Sales Market Share by Type (2017-2028)
Figure 61. South America Hospital Acquired Disease Testing Sales Market Share by Application (2017-2028)
Figure 62. South America Hospital Acquired Disease Testing Revenue Market Share by Country (2017-2028)
Figure 63. Brazil Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Argentina Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Middle East and Africa Hospital Acquired Disease Testing Sales Market Share by Type (2017-2028)
Figure 66. Middle East and Africa Hospital Acquired Disease Testing Sales Market Share by Application (2017-2028)
Figure 67. Middle East and Africa Hospital Acquired Disease Testing Revenue Market Share by Country (2017-2028)
Figure 68. Turkey Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Saudi Arabia Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. UAE Hospital Acquired Disease Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source
  • Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028
    Published: 10-Jan-2024        Price: US 4950 Onwards        Pages: 309
    “Rising focus on decentralized diagnostics is driving the overall growth of the infectious disease diagnostics market.” The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. The rising focus on decentralized diagnostics and the growing demand for CLIA-waived PoC tests have driven the use of PoC technologies. The trend towa......
  • Global Pharmaceutical Testing Services Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 102
    Pharmaceutical Testing Service is often used to identify The chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical's solubility and can predict The medication's ability to reach a specific target within The body. Testing may even reveal contamination in The manufacturing production process or highlight other,......
  • Global Pharmaceutical Testing Services Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Pharmaceutical Testing Services market size was valued at US$ 3398.6 million in 2023. With growing demand in downstream market, the Pharmaceutical Testing Services is forecast to a readjusted size of US$ 7008.4 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Pharmaceutical Testing Services market. Pharmaceutical Testing Services are expected to show ......
  • Global Helicobacter Pylori Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Helicobacter Pylori Diagnostics market size was valued at US$ 624.1 million in 2023. With growing demand in downstream market, the Helicobacter Pylori Diagnostics is forecast to a readjusted size of US$ 1040.4 million by 2030 with a CAGR of 7.6% during review period. The research report highlights the growth potential of the global Helicobacter Pylori Diagnostics market. Helicobacter Pylori Diagnostics are expected to show st......
  • Global Laboratory-developed Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Laboratory-developed Testing market size was valued at US$ 3442.2 million in 2023. With growing demand in downstream market, the Laboratory-developed Testing is forecast to a readjusted size of US$ 4512 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Laboratory-developed Testing market. Laboratory-developed Testing are expected to show stable growth i......
  • Global Laboratory-developed Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 109
    According to our (Global Info Research) latest study, the global Laboratory-developed Testing market size was valued at USD 3620.6 million in 2023 and is forecast to a readjusted size of USD 4649.1 million by 2030 with a CAGR of 3.6% during review period. Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vit......
  • Global Pharmaceutical Testing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 151
    According to our (Global Info Research) latest study, the global Pharmaceutical Testing Services market size was valued at USD 3574.8 million in 2023 and is forecast to a readjusted size of USD 6987.8 million by 2030 with a CAGR of 10.0% during review period. Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and s......
  • Global TB Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global TB Diagnostic market: According to our latest research, the global TB Diagnostic market looks promising in the next 5 years. As of 2022, the global TB Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global TB Diagnostic market, with a sys......
  • IVD Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for IVD Products, with both quantitative a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs